WALTHAM, Mass., Aug. 7, 2019 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the second quarter ended June 30, 2019. In addition, the Company provided a clinical and business update. As

BOSTON, Aug. 7, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced financial results for the second quarter ended

NASHVILLE, Tenn., Aug. 7, 2019 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ:TVTY) today announced financial results for the second quarter ended June 30, 2019.

CHESTERFIELD, Mo., Aug. 7, 2019 /PRNewswire/ -- Reliv International, a 30-year-old wellness company located in Chesterfield, MO, announced today that Dr. Alfredo Galvez has been appointed as the company's Chief Scientific Advisor. Galvez has been associated with Reliv since 2013 and is best kn

NASDAQ, TSX: NVCNRecent HighlightsReceived Guidance from FDA to explore a potential Humanitarian Device Exemption Pathway for Neovasc Reducer™ (the "Reducer") for CCS class IV patients and to meet for another Sprint discussion Closed Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the second quarter ende

CHICAGO, Aug. 7, 2019 /PRNewswire/ -- CommonSpirit Health, the $29 billion nonprofit Catholic health system operating in 21 states, today announced the next s

NEWTOWN SQUARE, Pa., Aug. 7, 2019 /PRNewswire/ -- Kibow® Biotech, Inc. will feature its RENADYL™, its proprietary probiotic for kidney health, at the 2019 American Association of Diabetic Educators (AADE) Conference from August 8-11 at the George R. Brown Convention Center in Houston,

NASHVILLE, Tenn., Aug. 7, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2019 financial results after the market closes on Wednesday, August 14, 2019.  A conference call and live Internet webcast will be held on Wednesday, August

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, today announced that it will issue financial results for its first quarter fiscal year 2020, ended June 30, 2019, at 4:15pm Eastern time on Wednesday, Augus